------------------------------------------------------------------------

Contents (.PDF)    Federal Register

Contents (.TXT)                      Vol. 64, No.83

Friday, April 29, 1999

------------------------------------------------------------------------

Food and Drug Administration
RULES
ANADA 200-232, CVM98164.  Implantation or Injectable Dosage Form New Animal Drugs;  Oxytetracycline Injection.   Pages 23186-23187  [TXT]  [PDF]
Freedom of Information Summary
Docket No. 98C-0041, CFSAN98127.  Listing of Color Additives for Coloring Sutures; [Phthalocyaninato(2-)] Copper.   Pages 23185-23186  [TXT]  [PDF]  Written objections and hearing requests by June 1, 1999
Finding of No Significant Impact
CVM9910.  Delegation of Authority and Organization; Center for Veterinary Medicine; Technical Amendment.   Pages 23184-23185  [TXT]  [PDF]
NOTICES
Docket No. 99N-0926, OC99100.  Agency Information Collection Activities: Proposed Collection; Comment Request; Regulations Under the Federal Import Milk Act.   Pages 23333-23334  [TXT]  [PDF]  Written comments by June 29, 1999.

Docket No. 99N-0780, OC9989.  Agency Information Collection Activities: Proposed Collection; Comment Request for Food Canning Establishment Registration, Process Filing and Record keeping for Acidified Foods and Thermally Processed Low-Acid Foods in Hermetically Sealed Containers.   Pages 23334-23336  [TXT]  [PDF]   Written comments by June 29, 1999.

Docket No. 98N-0320, OC98370. Agency Information Collection Activities; Submission for OMB Review; Comment Request; Notification of a Health Claim or a Nutrient Content Claim Based on an Authoritative Statement.   Pages 23336-23337 [TXT]  [PDF] Written comments by June 1, 1999.

Docket No. 99F-1074, CFSAN9952.  Life Technologies, Inc.; Filing of Food Additive Petition.   Pages 23337-23338  [TXT]  [PDF]  

Docket No. 90F-0018, CFSAN9945.  Rohm and Haas Co.; Withdrawal of Food Additive Petition.   Page 23338 [TXT]  [PDF]

Docket No. 98E-0488, OC9972.  Determination of Regulatory Review Period for Purposes of Patent Extension; Gonal.   Pages 23338-23339  [TXT]  [PDF]

Docket No. 98E-0846, OC9949.  Determination of Regulatory Review Period for Purposes of Patent Extension; Apligraf.   Pages 23339-23340  [TXT]  [PDF]

OC99106.  Subcommittee Meeting of the Advisory Committee for Reproductive Health Drugs; Notice of Meeting.   Page 23340  [TXT]  [PDF]

Docket No. 99N-0872, CDER98208.  Revocation of Office of Generic Drug's Interim Policy Statement on Inactive Ingredients.   Pages 23340-23341  [TXT]  [PDF]